Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.' 2025-12-08 14:36
GC Biopharma's Varicella Vaccine Strain 'MAV/06' Listed in WHO Position Paper 2025-12-02 13:00
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine' 2025-11-03 13:26
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine 2025-10-13 12:38
GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea 2025-09-23 09:41
GC Biopharma's Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE-Indexed Journal 2025-08-21 13:00
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies 2025-08-18 12:40
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam 2025-07-17 13:56
GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal 2025-05-30 15:02
GC Biopharma Receives FDA Approval for its U.S. Plasma Collection Center in Calexico, California 2025-05-14 13:21
GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine 2025-04-09 12:00
GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025 2025-02-11 16:40
GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment 2024-11-26 08:44
GC Biopharma and Novelty Nobility Enter into Joint Research and Development Agreement for Geographic Atrophy Therapies 2024-10-29 09:13
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA 2024-09-03 15:59
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group 2024-06-20 08:44
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A 2024-06-10 16:18
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings 2024-06-04 13:00
GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor 2024-05-28 23:00
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance 2024-05-21 15:12
1 2 3